Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Yuhao TanGraduate Group in Genomics and Computational Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.ORCID 0000-0003-3040-1684
Lida WangInstitute for Personalized Medicine, College of Medicine, Pennsylvania State University, Hershey, PA, USA.ORCID 0000-0002-7990-7347
Hongyi ZhangCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Mingyao PanCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID 0000-0003-2912-9599
Dajiang J LiuInstitute for Personalized Medicine, College of Medicine, Pennsylvania State University, Hershey, PA, USA. dajiang.liu@psu.edu.ORCID 0000-0001-6553-858X
Xiaowei ZhanQuantitative Biomedical Research Center, Peter O'Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA. xiaowei.zhan@utsouthwestern.edu.ORCID 0000-0002-6249-7193
Bo LiGraduate Group in Genomics and Computational Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. lib3@chop.edu.ORCID 0000-0002-8617-900X
Funding
Methods to unveil sex-specific genetic architecture in trans-ancestry meta-analysisR01HG011035 · NHGRI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Bibo Jiang · 2022 to 2026
$3.8M
Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer DiagnosisR01CA258524 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Jayanthi S Lea, Bo Li · 2022 to 2026
$3.8M
Integrative approaches to understand systemic lupus erythematosus etiology in trans-ancestry genetic studiesR01AI174108 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Laura Carrel, Dajiang Liu · 2022 to 2026
$2.8M
Integrative genomic and geospatial analysis of insurance claim, biobank and GWAS summary statistics for complex traitsR01ES036042 · NIEHS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Bibo Jiang · 2023 to 2026
$2.1M
Antigen-independent prediction and biomarker identification of cancer-specific T cellsR01CA245318 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI LI, BO · 2020 to 2024
$1.9M
Multi-omic Characterization of COPD in FemalesR01HL173869 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Dajiang Liu, ANI Wang MANICHAIKUL · 2024 to 2026
$1.7M
Antibiotic Resistance Determination Utilizing Machine LearningU01AI169298 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GREENBERG, DAVID ELIHU, ZHAN, XIAOWEI · 2022 to 2024
$1.4M
Methods and tools to integrate multi-omics datasets to understand preclinical autoimmune and immune-mediated diseasesU01AI185638 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Dajiang Liu · 2024 to 2026
Bridging the gap between genotype and phenotype in GWAS studies is challenging. A multitude of genetic variants have been associated with immune-related diseases, including cancer, yet the interpretability of most variants remains low. Here, we investigate the quantitative components in the T cell receptor (TCR) repertoire, the frequency of clusters of TCR sequences predicted to have common antigen specificity, to interpret the genetic associations of diverse human diseases. We first developed a statistical model to predict the TCR components using variants in the TRB and HLA loci. Applying this model to over 300,000 individuals in the UK Biobank data, we identified 2309 associations between TCR abundances and various immune diseases. TCR clusters predicted to be pathogenic for autoimmune diseases were significantly enriched for predicted autoantigen-specificity. Moreover, four TCR clusters were associated with better outcomes in distinct cancers, where conventional GWAS cannot identify any significant locus. Collectively, our results highlight the integral role of adaptive immune responses in explaining the associations between genotype and phenotype.
Indexed as
Genome-Wide Association StudyPhenotypeReceptors, Antigen, T-CellAutoimmune DiseasesGenetic Predisposition to DiseaseGenotypeHumansNeoplasmsReceptors, Antigen, T-Cell
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Interpretable GWAS by linking clinical phenotypes to quantifiable immune repertoire components. · full record | OpenQuestion